Faculty of Pharmacy and Pharmaceutical Sciences

Skip to content | Change text size

print version

Monash University

Monash University Handbook 2011 Undergraduate - Unit

6 points, SCA Band 0 (NATIONAL PRIORITY), 0.125 EFTSL

Refer to the specific census and withdrawal dates for the semester(s) in which this unit is offered.

FacultyFaculty of Pharmacy and Pharmaceutical Sciences
OfferedSunway Second semester 2011 (Day)
Parkville Second semester 2011 (Day)
Coordinator(s)Dr Richard Prankerd (Parkville); Dr Lee Wang Wang (Sunway)


This unit aims to equip students with fundamental and applied knowledge required to understand and assess pharmaceutical pre-formulation, formulation, sterilization and packaging of parenteral products, with special emphasis on drug product stability, including the kinetics and mechanisms of drug degradation and functional group reactivity. The unit is also designed to provide students with an understanding of aseptic processing, disinfection and preservation.

This will involve the study of:

  • Preformulation/Formulation/ Containers and Closures
  • Drug Stability
  • Contamination control and sterilisation
  • Biotechnology products


At the end of this unit students will be able to:

  1. Estimate rate constants, half-lives and shelf-lives for drug substances and products; Interpret pH-rate profiles for typical drugs and understand the main physicochemical properties that control chemical reaction rates.
  2. Understand organic chemical reaction mechanisms for degradation of common drug functional groups; apply this knowledge to stabilization of drugs that are susceptible to hydrolysis, oxidation and photochemical degradation.
  3. Understand basic features of drug inactivation by physical means.
  4. Provide a summary of the necessary preformulation tools for new drug characterisation.
  5. Given information on the bulk, physicochemical and stability properties of a drug, provide a clear strategy for the choice and development of a formulation of that drug.
  6. Discuss the formulation of injections, including the purpose of all excipients used, and the general processes for the manufacture of injections including reconstitutable injections.
  7. Discuss issues in the use of glass, plastic and rubber packaging materials.
  8. Discuss contamination control and aseptic processing of sterile pharmaceuticals.
  9. Describe sterilization processes, validation, sterility assurance and end product sterility testing.
  10. Discuss microbial stability issues of pharmaceuticals and principles and practices of disinfection and preservation.
  11. Appreciate the spectrum of disciplines involved in pharmaceutical biotechnology products.


Final exam (2.5 hour): 80%; workshop assessments: 20%.

Chief examiner(s)

Dr Richard Prankerd

Contact hours

35 x 1hour lectures, 4 x 3hour workshops.



Additional information on this unit is available from the faculty at: